Eloxx Pharmaceuticals, Inc. (ELOX)
19.99
-0.98
(-4.70%)
USD |
OTCM |
Aug 24, 16:00
Eloxx Pharmaceuticals Shareholders Equity (Quarterly) : 46.42M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.42M |
| March 31, 2026 | -7.584M |
| June 30, 2025 | |
| September 30, 2023 | -20.05M |
| June 30, 2023 | -18.60M |
| March 31, 2023 | -16.29M |
| December 31, 2022 | -10.66M |
| September 30, 2022 | -4.982M |
| June 30, 2022 | 1.812M |
| March 31, 2022 | 11.69M |
| December 31, 2021 | 22.38M |
| September 30, 2021 | 33.00M |
| June 30, 2021 | 40.64M |
| March 31, 2021 | 2.75M |
| December 31, 2020 | 10.23M |
| September 30, 2020 | 15.08M |
| June 30, 2020 | 20.29M |
| March 31, 2020 | 26.26M |
| December 31, 2019 | 36.21M |
| September 30, 2019 | 45.23M |
| June 30, 2019 | 55.22M |
| March 31, 2019 | 34.43M |
| December 31, 2018 | 42.91M |
| September 30, 2018 | 51.46M |
| June 30, 2018 | 59.92M |
| Date | Value |
|---|---|
| March 31, 2018 | 13.50M |
| June 30, 2017 | 0.8712M |
| March 31, 2017 | 2.585M |
| December 31, 2016 | 2.842M |
| September 30, 2016 | 3.626M |
| June 30, 2016 | 4.561M |
| March 31, 2016 | 5.642M |
| December 31, 2015 | 8.725M |
| September 30, 2015 | 12.51M |
| June 30, 2015 | 12.22M |
| March 31, 2015 | 11.21M |
| December 31, 2014 | 11.94M |
| September 30, 2014 | 22.43M |
| June 30, 2014 | 27.49M |
| March 31, 2014 | 9.805M |
| December 31, 2013 | 7.720M |
| September 30, 2013 | 2.118M |
| June 30, 2013 | 3.786M |
| March 31, 2013 | 3.312M |
| December 31, 2012 | 1.581M |
| September 30, 2012 | 2.629M |
| June 30, 2012 | 3.453M |
| March 31, 2012 | 4.599M |
| December 31, 2011 | 2.833M |
| September 30, 2011 | 3.933M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 63.61M |
| CorMedix, Inc. | 460.83M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 0.8373M |
| BioStem Technologies, Inc. | 27.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.39M |
| Total Liabilities (Quarterly) | 16.97M |
| Current Ratio | 3.736 |
| Net Debt Paydown Yield | 2.23% |